Shenzhen Edge Medical rises on AI model investment to boost surgical robotics ambitions

Shenzhen Edge Medical

27/07/2026 07:37

** Shares of Shenzhen Edge Medical 2675.HK rise 6.2% to HK$40.50, outpacing a 1.01% climb in benchmark Hang Seng Index .HSI
** The surgical robots developer says it has completed the investment in PrimalVerse (Beijing) Technology, an AI enterprise specializing in R&D of foundation models for fifth-generation multi-modal 4D world models 
** "The investment will further enhance the company's capabilities in exploring the intelligent surgery field of 'AI + surgical robots' and establish a strategic foundation for the company's embodied AI surgical robot business," Shenzhen Edge says 
** Since debut on January 8, stock down 7.5% from the offer price of HK$43.24 apiece  
** YTD, Hang Seng Biotech Index .HSBIO down 0.7%



 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))